Afore Capital, a venture firm specializing in pre-seed investments, has raised $185 million for its fourth fund, expanding its ability to back early-stage founders.
Afore Capital, a venture firm specializing in pre-seed investments, has raised $185 million for its fourth fund, expanding its ability to back early-stage founders.
Hilversum-based Polestar Capital, a Dutch asset manager and impact investor, has introduced the €500 million Polestar Capital e-Mobility & Infrastructure Fund (PCEIF) to support zero-emission mobility projects.
Austin-based defense tech startup Saronic has secured $600 million in Series C funding to develop Port Alpha, an advanced factory for producing autonomous warships.
Augury, an industrial AI startup specializing in machine health monitoring, has secured $75 million in Series F funding, pushing its valuation past $1 billion.
As uncertainty looms over NIH funding, biotech leaders are stepping up with alternative financing solutions. Chris Gibson, co-founder and CEO of Recursion, along with serial biotech entrepreneur David Bearss, has launched the Altitude Lab Pre-seed Venture Fund, aimed at supporting early-stage biotech startups that typically rely on Small Business Innovation
BDC Capital, the venture arm of the Business Development Bank of Canada (BDC), has announced nearly $1 billion in new fund commitments aimed at late-stage Canadian tech companies.
Hightouch, a customer data platform (CDP) and AI-driven marketing automation startup, has secured $80 million in Series C funding, doubling its valuation to $1.2 billion.
